Stockscreener 앱 받기
12.00
3.27%
0.38
전일 마감가:
$11.62
열려 있는:
$11.63
하루 거래량:
1.14M
Relative Volume:
1.03
시가총액:
$1.17B
수익:
-
순이익/손실:
$-137.25M
주가수익비율:
-6.3492
EPS:
-1.89
순현금흐름:
$-121.97M
1주 성능:
+14.50%
1개월 성능:
+17.30%
6개월 성능:
+115.05%
1년 성능:
+17.07%
1일 변동 폭
$11.50
$12.05
1주일 범위
$10.11
$12.05
52주 변동 폭
$3.8951
$14.67
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
명칭
Oric Pharmaceuticals Inc
전화
(650) 388-5600
주소
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
ORIC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
12.00 | 1.13B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-07-08 | 개시 | Ladenburg Thalmann | Buy |
| 2024-10-31 | 개시 | Wells Fargo | Overweight |
| 2024-09-06 | 개시 | Stifel | Buy |
| 2024-02-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-09-22 | 개시 | Wedbush | Outperform |
| 2023-03-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-03-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-07-18 | 재개 | Oppenheimer | Perform |
| 2022-04-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-03-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-03-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-01-25 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-08-13 | 개시 | Robert W. Baird | Outperform |
| 2020-08-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-05-19 | 개시 | Citigroup | Neutral |
| 2020-05-19 | 개시 | Guggenheim | Buy |
| 2020-05-19 | 개시 | JP Morgan | Overweight |
| 2020-05-19 | 개시 | Jefferies | Buy |
모두보기
Oric Pharmaceuticals Inc 주식(ORIC)의 최신 뉴스
Will ORIC Pharmaceuticals Inc. stock attract ESG investors2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Is ORIC Pharmaceuticals Inc. stock poised for growthPortfolio Value Summary & AI Forecasted Entry and Exit Points - newser.com
How higher bond yields impact ORIC Pharmaceuticals Inc. (4TZ) stock2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com
ORIC Pharmaceuticals Inc 4TZ Stock Analysis and ForecastMarket Correction Analysis & Expert-Backed Recommendations That Deliver - earlytimes.in
Published on: 2025-09-29 09:52:14 - newser.com
Candlestick signals on ORIC Pharmaceuticals Inc. stock todayRisk Management & Consistent Profit Alerts - newser.com
Identifying reversal signals in ORIC Pharmaceuticals Inc.July 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
Top chart patterns to watch in ORIC Pharmaceuticals Inc.Trade Performance Summary & Growth Focused Entry Point Reports - newser.com
ORIC Pharmaceuticals Inc Stock Analysis and ForecastLow Risk Investment Ideas & Learn the Secrets of Pro Traders - Early Times
Merus NV and ORIC Pharmaceuticals Inc at Citi BioPharma Conferen - GuruFocus
How robust is ORIC Pharmaceuticals Inc. (4TZ) stock financial positionMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com
Cantor Fitzgerald reiterates Overweight rating on ORIC Pharmaceuticals stock By Investing.com - Investing.com Canada
Palumbo Wealth Management LLC Takes Position in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) CEO Sells $1,350,000.00 in Stock - MarketBeat
Rhumbline Advisers Decreases Stock Position in Oric Pharmaceuticals, Inc. $ORIC - Defense World
Should you hold or exit ORIC Pharmaceuticals Inc. now2025 Year in Review & Daily Profit Maximizing Tips - newser.com
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $17.29 Average PT from Analysts - MarketBeat
Real time scanner hits for ORIC Pharmaceuticals Inc. explainedTrade Risk Assessment & Expert Approved Momentum Trade Ideas - newser.com
How to use a screener to detect ORIC Pharmaceuticals Inc. breakoutsTake Profit & Verified Momentum Stock Ideas - newser.com
Stock Recap: What are ORIC Pharmaceuticals Incs recent SEC filings showingWeekly Investment Report & Advanced Swing Trade Entry Alerts - خودرو بانک
Is ORIC Pharmaceuticals Inc. trending in predictive chart modelsJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com
US Stocks Recap: Does ORIC Pharmaceuticals Inc. align with a passive investing strategyJuly 2025 Breakouts & Verified Momentum Watchlists - خودرو بانک
Will ORIC Pharmaceuticals Inc. outperform the marketShort Setup & Weekly Market Pulse Updates - newser.com
Risk Check: What’s ORIC Pharmaceuticals Inc.’s historical return2025 Sector Review & Smart Money Movement Tracker - خودرو بانک
How institutional ownership impacts ORIC Pharmaceuticals Inc. stockJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
How to recover losses in ORIC Pharmaceuticals Inc. stockEarnings Risk Report & Safe Entry Zone Identification - newser.com
Quarterly Risk: Will ORIC Pharmaceuticals Inc benefit from current market trendsLayoff News & Safe Entry Point Identification - خودرو بانک
Published on: 2025-09-18 21:52:52 - newser.com
Aug Wrap: Is ORIC Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Reactions & Real-Time Chart Pattern Alerts - خودرو بانک
Oric Pharmaceuticals Inc (ORIC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):